Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/HINI 2009

被引:89
作者
Hardelid, P. [2 ]
Andrews, N. J. [2 ]
Hoschler, K. [3 ]
Stanford, E. [4 ]
Baguelin, M. [1 ]
Waight, P. A. [1 ]
Zambon, M. [3 ]
Miller, E. [1 ]
机构
[1] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, Ctr Infect, London, England
[2] Hlth Protect Agcy, Stat Unit, Ctr Infect, London, England
[3] Hlth Protect Agcy, Virus Reference Dept, Ctr Infect, Resp Virus Unit, London, England
[4] Manchester Royal Infirm, Hlth Protect Agcy, Vaccine Evaluat Seroepidemiol Unit, Manchester M13 9WL, Lancs, England
关键词
MONOCLONAL-ANTIBODIES; PROTECTIVE IMMUNITY; VIRUSES; RESPONSES; ENGLAND;
D O I
10.3310/hta14550-03
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The objectives of the HINI 2009 serological surveillance project were twofold: to document (1) the prevalence of cross-reactive antibodies to HINI 2009 by age group in the population of England prior to arrival of the pandemic strain virus in the UK and (2) the age-specific incidence of infection by month as the pandemic progressed by measuring increases in the proportion of individuals with antibodies to HINI 2009 by age. Methods: Residual aliquots of samples submitted to 16 microbiology laboratories in eight regions in England in defined age groups in 2008 and stored by the Health Protection Agency serological surveillance programme were used to document age-stratified prevalence of antibodies to HINI 2009 prior to the arrival of the pandemic in the UK. Functional antibodies to the HINI 2009 virus were measured by haemagglutination inhibition (HI) and microneutralisation (MN) assays. For timely measurement of monthly incidence of infection with HINI 2009 between August 2009 and April 2010, the microbiology serum collections were supplemented by collection of residual sera from chemical pathology laboratories in England. Monthly seroincidence samples were tested by HI only, apart from the final sera collected post pandemic in 2010, which were also tested by MN. Incidence during the pandemic was estimated from changes in prevalence between time points and also by a likelihood-based method. Setting: Eight regions of England. Participants: Serum samples from patients accessing health care in England from whom blood samples were taken for unrelated microbiological or chemical pathology testing. Interventions: None. Main outcome measures: Baseline age-specific prevalence of functional antibodies to the HI NI 2009 virus prior to the arrival of the pandemic; changes in antibody prevalence during the period August 2009 to April 2010. Results: Pre-existing cross-reactive antibodies to HINI 2009 were detected in the baseline sera and increased with age, particularly in those born before 1950. The prediction of immunological protection derived from the baseline serological analysis was consistent with the lower clinical attack rates in older age groups. The high levels of susceptibility in children < 15 years, together with their mixing within school, resulted in the highest attack rates in this age group. Serological analysis by region confirms that there were geographical differences in timing of major pandemic waves. London had a big first wave among the 5- to 14-year age group, with the rest of the country reducing the gap after the second wave. Cumulative incidence in London remained higher throughout the pandemic in each age group. By the end of the second wave it is estimated that as many as 70% of school-aged children in London had been infected. Taken together, these observations are consistent with observations from previous pandemics in 1918, 1957 and 1968 that the major impact of influenza pandemics is on younger age groups, with a pattern of morbidity and mortality distinct from seasonal influenza epidemics. Conclusions: Serological analysis of appropriately structured, age-stratified and geographically representative samples can provide an immense amount of information to set in context other measures of pandemic impact in a population, and provide the most accurate measures of population exposure. National scale seroepidemiology studies require cross-agency coordination, multidisciplinary working, and considerable scientific resource.
引用
收藏
页码:115 / +
页数:68
相关论文
共 43 条
  • [31] Social contacts and mixing patterns relevant to the spread of infectious diseases
    Mossong, Joeel
    Hens, Niel
    Jit, Mark
    Beutels, Philippe
    Auranen, Kari
    Mikolajczyk, Rafael
    Massari, Marco
    Salmaso, Stefania
    Tomba, Gianpaolo Scalia
    Wallinga, Jacco
    Heijne, Janneke
    Sadkowska-Todys, Malgorzata
    Rosinska, Magdalena
    Edmunds, W. John
    [J]. PLOS MEDICINE, 2008, 5 (03) : 381 - 391
  • [32] *OFF NAT STAT, 2009 MID POP EST
  • [33] RAPID FOCUS REDUCTION NEUTRALIZATION TEST OF INFLUENZA-A AND INFLUENZA-B VIRUSES IN MICROTITER SYSTEM
    OKUNO, Y
    TANAKA, K
    BABA, K
    MAEDA, A
    KUNITA, N
    UEDA, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (06) : 1308 - 1313
  • [34] Ten years of serological surveillance in England and Wales: methods, results, implications and action
    Osborne, K
    Gay, N
    Hesketh, L
    Morgan-Capner, P
    Miller, E
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (02) : 362 - 368
  • [35] Osborne K, 1997, Euro Surveill, V2, P29
  • [36] *ROYAL COLL GEN PR, ANN REP 2009
  • [37] Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
    Stephenson, Iain
    Heath, Alan
    Major, Diane
    Newman, Robert W.
    Hoschler, Katja
    Junzi, Wang
    Katz, Jacqueline M.
    Weir, Jerry P.
    Zambon, Maria C.
    Wood, John M.
    [J]. EMERGING INFECTIOUS DISEASES, 2009, 15 (08) : 1250 - 1259
  • [38] BROADLY CROSS-REACTIVE MONOCLONAL ANTIBODIES AGAINST HA2 GLYCOPEPTIDE OF INFLUENZA A VIRUS HEMAGGLUTININ OF H3 SUBTYPE REDUCE REPLICATION OF INFLUENZA A VIRUSES OF HUMAN AND AVIAN ORIGIN
    Stropkovska, A.
    Mucha, V.
    Fislova, T.
    Gocnik, M.
    Kostolansky, F.
    Vareckova, E.
    [J]. ACTA VIROLOGICA, 2009, 53 (01) : 15 - 20
  • [39] Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus
    Tumpey, TM
    Garcia-Sastre, A
    Taubenberger, JK
    Palese, P
    Swayne, DE
    Basler, CF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) : 3166 - 3171
  • [40] VANHOEK AJ, RESPONSE GUEST EDITO